These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 7418239

  • 1. [Effects of chlorpromazine, beta-endorphin and vasoactive intestinal polypeptide on plasma growth hormone levels in unanesthetized rats (author's transl)].
    Wakabayashi I, Miyoshi H, Oomura E, Shizume K.
    Horumon To Rinsho; 1980; 28(6):633-8. PubMed ID: 7418239
    [No Abstract] [Full Text] [Related]

  • 2. Vasoactive intestinal peptide: evidence for a hypothalamic site of action to release growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats.
    Vijayan E, Samson WK, Said SI, McCann SM.
    Endocrinology; 1979 Jan; 104(1):53-7. PubMed ID: 446354
    [No Abstract] [Full Text] [Related]

  • 3. [Effects of intrathecal injection of beta-endorphin on endocrine function in man (author's transl)].
    Yamaya R.
    Masui; 1981 May; 30(5):445-52. PubMed ID: 6268860
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of acetylcholine, bradykinin, and vasoactive intestinal polypeptide on the canine airways and pulmonary vascular bed (author's transl)].
    Sugiyama Y, Hsu LH, Ishihara Y, Kitamura S, Kosaka K.
    Kokyu To Junkan; 1982 Apr; 30(4):387-91. PubMed ID: 7100681
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
    Hara N, Yosida T, Said SI.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec; 16(11):840-5. PubMed ID: 739695
    [No Abstract] [Full Text] [Related]

  • 6. Effects of beta-endorphin, vasoactive intestinal polypeptide and cholecystokinin octapeptide on cat carotid chemoreceptor activity.
    McQueen DS, Ribeiro JA.
    Q J Exp Physiol; 1981 Jul; 66(3):273-84. PubMed ID: 6166957
    [Abstract] [Full Text] [Related]

  • 7. [Regulation of gastrointestinal motility by gastrointestinal hormones (author's transl)].
    Takeuchi S, Ito S.
    Horumon To Rinsho; 1979 Jul; 27(12):1379-85. PubMed ID: 397014
    [No Abstract] [Full Text] [Related]

  • 8. Effect of vasoactive intestinal peptide (VIP) on somatostatin inhibition of pituitary growth hormone secretion in vitro.
    Tapia-Arancibia L, Arancibia S, Bluet-Pajot MT, Enjalbert A, Epelbaum J, Priam M, Kordon C.
    Eur J Pharmacol; 1980 May 02; 63(2-3):235-6. PubMed ID: 6103817
    [No Abstract] [Full Text] [Related]

  • 9. [Dexamethasone regulation of the prolactin release induced by vasoactive intestinal peptide (VIP)].
    Rotsztejn W, Benoist L, Besson J, Duval J.
    C R Seances Acad Sci D; 1980 Mar 24; 290(12):791-3. PubMed ID: 6769606
    [Abstract] [Full Text] [Related]

  • 10. Vasoactive intestinal peptide stimulates hormone release from corticotropic cells in culture.
    Westendorf JM, Phillips MA, Schonbrunn A.
    Endocrinology; 1983 Feb 24; 112(2):550-7. PubMed ID: 6129133
    [No Abstract] [Full Text] [Related]

  • 11. Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal polypeptide and gastrin/CCK immunoractive nerves.
    Larsson LI.
    J Histochem Cytochem; 1979 Sep 24; 27(9):1283-4. PubMed ID: 479572
    [Abstract] [Full Text] [Related]

  • 12. Effect of vasoactive intestinal polypeptide on prolactin release in vitro.
    Shaar CJ, Clemens JA, Dininger NB.
    Life Sci; 1979 Sep 24; 25(24-25):2071-4. PubMed ID: 537469
    [No Abstract] [Full Text] [Related]

  • 13. Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones.
    Fuxe K, Andersson K, Hökfelt T, Mutt V, Ferland L, Agnati LF, Ganten D, Said S, Eneroth P, Gustafsson JA.
    Fed Proc; 1979 Aug 24; 38(9):2333-40. PubMed ID: 222624
    [Abstract] [Full Text] [Related]

  • 14. [Neuropeptides and the secretion of pituitary hormone (author's transl)].
    Wakabayashi I, Shizume K.
    No To Shinkei; 1980 May 24; 32(5):505-14. PubMed ID: 6104972
    [No Abstract] [Full Text] [Related]

  • 15. [Vasoactive intestinal polypeptide (VIP) (author's transl)].
    Kachelhoffer J, Marescaux J, Michel F, Grenier JF.
    Gastroenterol Clin Biol; 1979 Apr 24; 3(4):381-95. PubMed ID: 499699
    [No Abstract] [Full Text] [Related]

  • 16. The influence of vasoactive intestinal polypeptide and cholecystokinin on prolactin release in rat and human monolayer cultures.
    Malarkey WB, O'Dorisio TM, Kennedy M, Cataland S.
    Life Sci; 1981 Jun 01; 28(22):2489-95. PubMed ID: 7253836
    [No Abstract] [Full Text] [Related]

  • 17. [Hypnogenic properties of the vasoactive intestinal polypeptide in rats].
    Riou F, Cespuglio R, Jouvet M.
    C R Seances Acad Sci III; 1981 Nov 30; 293(12):679-82. PubMed ID: 6460548
    [Abstract] [Full Text] [Related]

  • 18. [Proceedings: Study of GIF (growth hormone inhibiting factor). (II). Effect of GIF on plasma GH and prolactin levels of rats treated with nembutol and chlorpromazine].
    Sawano S, Kokubu T, Ishizuka Y, Baba Y.
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb 20; 50(2):269. PubMed ID: 4477081
    [No Abstract] [Full Text] [Related]

  • 19. Excitation of CA1 neurones of the rat hippocampus by the octacosapeptide, vasoactive intestinal polypeptide (VIP) [proceedings].
    Dodd J, Kelly JS, Said SI.
    Br J Pharmacol; 1979 May 20; 66(1):125P. PubMed ID: 454920
    [No Abstract] [Full Text] [Related]

  • 20. Vasodilatory effects of vasoactive intestinal polypeptide (VIP) on isolated rat arteries.
    Suzuki Y, Kobayashi Y, Lederis K.
    Proc West Pharmacol Soc; 1983 May 20; 26():341-4. PubMed ID: 6889362
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.